Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MNPR stock hub

Monopar Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MNPRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

425.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MNPR

In the news

Latest news · MNPR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-14.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-10.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MNPR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001645469
Company name	Monopar Therapeutics Inc.
Country	United States
Country code	US
Cusip	61023L108
Employees	22
Employees Change	6%
Employees Change Percent	37.5
Enterprise value	$285.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-12-19
Isin	US61023L2079
Last refreshed	2026-05-10
Market cap	$425.5M
Market cap category	Small-Cap
Price	$63.58
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	MNPR
Website	https://www.monopartx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.22%
P/B ratio	3.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-13.7M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-623,495
ROA	-10.39
Roa5y	-32.69
ROCE	-12.11
ROE	-14.22
Roe5y	-59.57
ROIC	-10.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	62.65%
Cagr3y	134.03%
Cagr5y	19.22%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$140.7M
Cash	$140.4M
Current Assets	$140.5M
Current Liabilities	$2.7M
Debt	$245,489
Debt Equity	$0
Equity	$137.8M
Liabilities	$2.9M
Long Term Assets	$254,921
Long Term Liabilities	$154,920
Net Cash	$140.2M
Net Cash By Market Cap	$32.94
Net Cash Growth	132.77%
Net Debt Equity	$-1.02
Tangible Book Value	$137.8M
Tangible Book Value Per Share	$20.6
WACC	12.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	51.35
Net Working Capital	$-2.6M
Quick ratio	51.33
Working Capital	$137.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-95.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	62.6%
200-day SMA	63.15
3Y total return	1,182.53%
50-day SMA	56.16
50-day SMA vs 200-day SMA	50under200
5Y total return	140.81%
All Time High	240
All Time High Change	-73.51%
All Time High Date	2019-12-20
All Time Low	1.37
All Time Low Change	4,540.51%
All Time Low Date	2023-11-27
ATR	3.93
Beta	1.5
Beta1y	0.47
Beta2y	1.58
Ch YTD	-2.64
High	65.58
High52	105
High52 Date	2025-10-06
High52ch	-39.45%
Low	61.56
Low52	28.4
Low52 Date	2025-05-30
Low52ch	123.86%
Ma50ch	13.2%
Price vs 200-day SMA	0.67%
RSI	65.86
RSI Monthly	60.91
RSI Weekly	53.32
Sharpe ratio	0.95x
Sortino ratio	1.63
Total Return	-95.53%
Tr YTD	-2.64
Tr1m	18.59%
Tr1w	19.39%
Tr3m	10.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	6
Analyst Price Target Top	$106
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.93
Operating Income	$-16.7M
Price target	$107
Price Target Change	$68.31
Price Target Change Top	$66.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,396,810%
Float Percent	65.7%
Shares Insiders	6.96%
Shares Institutions	63.07%
Shares Out	6,692,140
Shares Qo Q	19.79%
Shares Yo Y	95.53%
Short Float	39.19%
Short Ratio	8.63
Short Shares	25.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	160,688.25x
Bv Per Share	20.6
Ch1m	18.59
Ch1w	19.39
Ch1y	62.6
Ch3m	10.09
Ch3y	1,182.5
Ch5y	140.8
Ch6m	-21.46
Change	1.83%
Change From Open	3.27
Close	62.43
Days Gap	-1.39
Dollar Volume	11,656,031.2
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-16.7M
EPS	$-1.85
F Score	2
Financing CF	91,574,402
Fiscal Year End	December
Founded	2,014
Investing CF	-63,453,114
Ipr	694.7
Iprfo	52.28
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Last Split Date	2024-08-13
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	68.27
Ma150ch	-6.87%
Ma20	55.92
Ma20ch	13.69%
Net CF	16,017,263
Next Earnings Date	2026-05-22
Open	61.56
Optionable	No
Position In Range	50.12
Post Close	63.58
Postmarket Change Percent	-1.99
Postmarket Price	$62.31
Ppne	254,921
Price Date	2026-05-08
Ptbv Ratio	3.09
Relative Volume	1.14x
Share Based Comp	4,837,877
Tr6m	-21.46%
Us State	Illinois
Volume	183,343

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MNPR pay a dividend?

Capital-return profile for this ticker.

Performance

MNPR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MNPR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.1%

Float: +65.7% of shares outstanding

Insider ownership

+7.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MNPR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.9

Neutral momentum band

Price vs 200-day MA

+0.7%

50/200-day relationship not available

Beta (5Y)

1.50

More volatile than the market

Sharpe ratio

0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MNPR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MNPR stock rating?

Monopar Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MNPR analysis?

The full report lives at /stocks/MNPR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MNPR?

The latest report frames MNPR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MNPR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.